The San Diego-based biotech said Wednesday during an earnings call that it's moving directly to a Phase 3 study of its drug, ...

Pfizer reported positive data for its gene therapy for hemophilia A, and yet early excitement about such therapy has been tempered by questions over durability and demand.

Jiankui He, who sparked a global uproar in 2018 when he revealed he had created gene-edited children, is out on his own after ...

CVS Caremark, one of the largest PBMs, agreed to pay at least $45 million to the state of Illinois to settle allegations that ...

Merck laid off around 75 to 80 people in its early research division this week. The move comes amid a series of layoffs from ...

Sage Therapeutics said an experimental pill failed to quell involuntary muscle shaking in patients with a neurological ...

CVS Caremark, one of the largest pharmacy benefit managers in the country, agreed to pay at least $45 million to the state of ...

One of largest studies using exoskeletons for rehab in children with cerebral palsy demonstrated a limited gain in gross ...

Sen. Bob Casey Jr. (D-Pa.) will introduce legislation Wednesday to strengthen and expand a critical part of the ...

Cell and gene therapy developers must demonstrate ethical leadership on behalf of blood and tissue donors while regulators ...

The U.S. is just beginning to experience the full impact of its aging population. Regrettably, its health care system and workforce are inadequately prepared to handle the surge of geriatric patients.

The VA is studying how removing race from widely used spirometry tests that measure lung function may affect disability ...